Interferon-γ, but not interferon-α, induces SOCS 3 expression in human melanoma cell lines

Melanoma Research

Volumn 15, Issue 6, 2005, Pages 481-488

  Kovarik, Ales ^a   Fojtova, Miloslava ^a   Boudny, Vladimir ^b   Adamkova, Lenka ^b   Lauerova, Ludmila ^b   Kovarik, Jan ^b  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

Interferons; Malignant melanoma; Signal transduction; SOCS 3; STAT 1

Indexed keywords

MESSENGER RNA; RECOMBINANT ALPHA INTERFERON; RECOMBINANT GAMMA INTERFERON; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TYROSINE; RECOMBINANT INTERFERON; SOCS3 PROTEIN, HUMAN; STAT1 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; KERATINOCYTE; MELANOCYTE; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN CELL; SKIN FIBROBLAST; TRANSCRIPTION REGULATION; BIOSYNTHESIS; CELL GROWTH; DRUG EFFECT; GENETICS; MELANOMA; METABOLISM; NORTHERN BLOTTING; PHOSPHORYLATION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL GROWTH PROCESSES; CELL LINE, TUMOR; HUMANS; INTERFERON TYPE I, RECOMBINANT; INTERFERON-GAMMA, RECOMBINANT; MELANOMA; PHOSPHORYLATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 33646973354     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200512000-00001     Document Type: Article

References (32)

1. Darnell JE Jr. STATs and gene regulation [review]. Science 1997; 277:1630-1635.
2. Fujimoto M, Naka T. Regulation of cytokine signaling by SOCS family molecules. Trends Immunol 2003; 24:659-666.
3. Greenhalgh CJ, Hilton DJ. Negative regulation of cytokine signaling. J Leuk Biol 2001; 70:348-356.
4. Schindler C, Darnell JE Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway [review]. Annu Rev Biochem 1995; 64:621-651.
5. Frank DA. STAT signaling in the pathogenesis and treatment of cancer [review]. Mol Med 1999; 5:432-456.
6. O'Shea JJ, Gadina M, Schreiber RD. Cytokine signaling in 2002: new surprises in the JAK/STAT pathway [review]. Cell 2002; 109 (Suppl):S121-S131.
7. Decker T, Kovarik P. Serine phosphorylation of STATs. Oncogene 2000; 19:2628-2637.
8. Kovarik P, Mangold M, Ramsauer K, Heidari H, Steinborn R, Zotter A, et al. Specificity of signaling by STAT 1 depends on SH2 and C-terminal domains that regulate Ser 727 phosphorylation, differentially affecting specific target gene expression. EMBO J 2001; 20:91-100.
9. Agaisse H, Perrimon N. The roles of JAK/STAT signaling in Drosophila immune responses. Immunol Rev 2004; 198:72-82.
10. Wang T, Niu G, Kortylewski M, Burdelya L, Shain K, Zhang S, et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med 2004; 10:48-54.
11. Anderson PO, Sundstedt A, Yazici Z, Minaee S, Woolf R, Nicolson K, et al. IL-2 overcomes the unresponsiveness but fails to reverse the regulatory function of antigen-induced T regulatory cells. J Immunol 2005; 174:310-319.
12. Cooney RN. Suppressors of cytokine signalling (SOCS): inhibitors of the JAK/STAT pathway. Shock 2002; 17:83-90.
13. Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A. STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 2003; 197:157-168.
14. He B, You L, Uematsu K, Zang K, Xu Z, Lee AY, et al. SOCS 3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci USA 2003; 100:14 133-14 138.
15. Cacalano NA, Sanden D, Johnston JA. Tyrosine-phosphorylated SOCS 3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat Cell Biol 2001; 3:460-465.
16. Pansky A, Hildebrand P, Fasler-Kan E, Baselgia L, Ketterer S, Beglinger C, Heim MH. Defective JAK-STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon-alpha. Int J Cancer 2000; 85:720-725.
17. Lesinski GB, Valentino D, Hade EM, Jones S, Chaudhury AR, Walker MJ, Carson WE 3rd. Expression of STAT 1 and STAT 2 in malignant melanoma does not correlate with response to interferon-alpha adjuvant therapy. Cancer Immunol Immunother 2005; 54:815-825.
18. Herlyn M, Thurin J, Balaban G, Bennicelli JL, Herlyn D, Elder DE, et al. Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 1985; 45:5670-5676.
19. Kovarik J, Boudny V, Kocak I, Lauerova L, Fait V, Vagundova M. Malignant melanoma associates with deficient IFN-induced STAT 1 phosphorylation. Int J Mol Med 2003; 12:335-340.
20. Kovarik P, Stoiber D, Novy M, Decker T. Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation. EMBO J 1998; 17:3660-3668.
21. Ramsauer K, Sadzak I, Porras A, Pilz A, Nebreda AR, Decker T, Kovarik P. p38 MAPK enhances STAT 1-dependent transcription independently of Ser-727 phosphorylation. Proc Natl Acad Sci USA 2002; 99:12859-12864.
22. Pilz A, Ramsauer K, Heidari H, Leitges M, Kovarik P, Decker T. Phosphorylation of the Stat1 transactivating domain is required for the response to type I interferons. EMBO Rep 2003; 4:368-373.
23. Masuhara M, Sakamoto H, Matsumoto A, Suzuki R, Yasukawa H, Mitsui K, et al. Cloning and characterization of novel CIS family genes. Biochem Biophys Res Commun 1997; 239:439-446.
24. Federici M, Giustizieri ML, Scarponi C, Girolomoni G, Albanesi C. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1. J Immunol 2002; 169:434-442.
25. Sakai I, Takeuchi K, Yamauchi H, Narumi H, Fujita S. Constitutive expression of SOCS 3 confers resistance to IFN alpha in chronic myelogenous leukemia cells. Blood 2002; 100:2926-2931.
26. Gatto L, Berlato C, Poli V, Tininini S, Kinjyo I, Yoshimura A, et al. Analysis of SOCS 3 promoter responses to interferon gamma. J Biol Chem 2004; 279:13746-13754.
27. Levy DE, Darnell JE Jr. STATs: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002; 3:651-662.
28. Wong LH, Krauer KG, Hatzinisiriou I, Estcourt MJ, Hersey P, Tam ND, et al. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT 1, STAT 2, and p48-ISGF3gamma. J Biol Chem 1997; 272:28779-28785.
29. Porta C, Hadj-Slimane R, Nejmeddine M, Pampin M, Tovey MG, Espert L, et al. Interferons alpha and gamma induce p53-dependent and p53-independent apoptosis, respectively. Oncogene 2005; 24:605-615.
30. Ramana CV, Gil MP, Han Y, Ransohoff RM, Schreiber RD, Stark GR. Stat 1-independent regulation of gene expression in response to IFN-gamma. Proc Natl Acad Sci USA 2001; 98:6674-6679.
31. Ramana CV, Kumar A, Enelow R. Stat1-independent induction of SOCS 3 by interferon-gamma is mediated by sustained activation of Stat 3 in mouse embryonic fibroblasts. Biochem Biophys Res Commun 2005; 327:727-733.
32. Li Z, Metze D, Nashan D, Muller-Tidow C, Serve HL, Poremba C, et al. Expression of SOCS 1, suppressor of cytokine signalling 1, in human melanoma. J Invest Dermatol 2004; 123:737-745.